FDA Black Box Label Warns of Suicide Risks
Akathisia is a Medication-Induced Disorder that is Often Misdiagnosed and Mistreated as a Mental Illness
CHICAGO, ILLINOIS, USA, May 26, 2022 /EINPresswire.com/ -- The Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin (MISSD) works to increase public awareness of adverse drug effects often misdiagnosed and mistreated as mental illnesses. "During Mental Health Awareness Month, we hear suicide prevention and mental health organizations promoting pharmaceutical products as treatments while staying silent about adverse drug effects that can harm our mental wellbeing," said Wendy Dolin, MISSD founder. "This is unfortunate given that candid discussions about real drug risks vs. possible benefits can save lives."
Akathisia is a medication-induced disorder that can cause a person to experience such intense inner restlessness that the sufferer is driven to self-harm, violence, or suicide. Medications that can induce akathisia include, but aren't limited to, drugs prescribed for acne, depression, high blood pressure, asthma, hair loss, and anxiety.
"Selective serotonin reuptake inhibitors (SSRIs) are one class of drugs that carry the US Food and Drug Administration's (FDA) black box warning of increased risks of suicidality for ages 24 and under," said Dolin. "However, SSRI consumers of all ages can develop akathisia. Commonly marketed as antidepressants, some SSRIs are best known by their brand names such as Prozac, Zoloft, and Paxil."
Inner symptoms of akathisia can include cognitive confusion (delirium), anxiety, insomnia, skin-crawling sensations, agitation, vivid nightmares, impulsivity, depersonalization, and unusual, repetitive thoughts and/or behaviors.
Outward signs of akathisia can include compulsive movements such as pacing, rocking back and forth, swinging legs, or marching in place; a distracted or distant "deer-in-the-headlights" look; and a change of gait such as shuffling one's feet when walking.
"It is essential that health care consumers and caregivers carefully read all patient information leaflets and watch for and report any unusual changes in behavior when starting, stopping, or changing dosage or type of SSRIs and other medications that can induce akathisia," said Dolin. "Akathisia awareness can reduce suffering and save lives by helping ensure this medication-induced disorder is identified promptly and treated appropriately."
MISSD, an authentic grassroots 501c3 nonprofit, accepts no funding from the pharmaceutical industry and provides all educational resources for free. See MISSD.co for conference presentations, informative videos, a podcast series, brochures, and an accredited e-learning course.
Wendy Dolin
MISSD
+1 847-910-2346
email us here
Visit us on social media:
Facebook
Twitter
Other
Akathisia: In Their Own Words
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.